-
公开(公告)号:US07074819B2
公开(公告)日:2006-07-11
申请号:US10640696
申请日:2003-08-12
申请人: Jae Chon Jo , Hyun Suk Lim , Jong Min Kim , Ju Su Kim , Kazumi Morikawa , Yoshitake Kanbe , Myung Hwa Kim , Masahiro Nishimoto
发明人: Jae Chon Jo , Hyun Suk Lim , Jong Min Kim , Ju Su Kim , Kazumi Morikawa , Yoshitake Kanbe , Myung Hwa Kim , Masahiro Nishimoto
IPC分类号: A61K31/38 , C07D335/04
CPC分类号: C07D335/06 , C07D311/58 , C07D405/04 , C07D405/06 , C07D407/06 , C07D413/06 , C07D417/06
摘要: The present invention relates to a novel benzopyran or thiobenzopyran derivative represented by formula (1): pharmaceutically acceptable salt or stereoisomer thereof, in which X, R1, R2, R3, R4 and A are defined as described in the specification, and to a process for preparation thereof and a pharmaceutical composition having anti-estrogenic activity which contains the compound (1) as an active component.
摘要翻译: 本发明涉及由式(1)表示的新的苯并吡喃或硫代苯并吡喃衍生物:其药学上可接受的盐或立体异构体,其中X,R 1,R 2,R R 3,R 4和A如说明书中所述定义,其制备方法和具有抗雌激素活性的药物组合物含有化合物(1 )作为活性成分。
-
公开(公告)号:US6153768A
公开(公告)日:2000-11-28
申请号:US319616
申请日:1999-06-08
申请人: Jae Chon Jo , Sung Dae Park , Hyun Suk Lim , Ju Su Kim , Sung Jin Kim , Kazumi Morikawa , Yoshitake Kanbe , Masahiro Nishimoto , Myung-Hwa Kim
发明人: Jae Chon Jo , Sung Dae Park , Hyun Suk Lim , Ju Su Kim , Sung Jin Kim , Kazumi Morikawa , Yoshitake Kanbe , Masahiro Nishimoto , Myung-Hwa Kim
IPC分类号: A61K31/352 , A61K31/353 , A61K31/382 , A61K31/453 , A61K31/496 , A61P5/32 , A61P15/00 , C07D311/38 , C07D311/58 , C07D335/06 , C07D311/04
CPC分类号: C07D335/06 , C07D311/38 , C07D311/58
摘要: The present invention relates to a novel benzopyran derivative having anti-estrogenic activity. More specifically, the present invention relates to a novel benzopyran derivative represented by formula (I) and pharmaceutically acceptable salt thereof, in which ----- represents a single bond or a double bond; R1 and R2 independently of one another represent hydrogen, hydroxy or OR group, wherein R represents acyl or alkyl; R3 represents hydrogen, lower alkyl or halogeno lower alkyl, provided that when ----- represents a double bond, R3 is not present; R4 represents hydrogen or lower alkyl; A represents a group of formula a, b, c or d; R5, R6 and R7 independently of one another represent hydrogen, alkyl, halogenoalkyl, alkenyl or halogenoalkenyl, or R6 and R7 together with nitrogen atom to which they are bound can form a 4- to 8-membered heterocyclic ring which can be substituted with R5; X represents O, S, or NR8, wherein R8 represents hydrogen or lower alkyl; m denotes an integer of 2 to 15; n denotes an integer of 0 to 2; and p denotes an integer of 0 to 4.
摘要翻译: PCT No.PCT / KR97 / 00265 Sec。 371 1999年6月8日第 102(e)日期1999年6月8日PCT 1997年12月13日PCT公布。 公开号WO98 / 25916 PCT 日期:1998年6月18日本发明涉及具有抗雌激素活性的新型苯并吡喃衍生物。 更具体地说,本发明涉及由式(I)表示的新型苯并吡喃衍生物及其药学上可接受的盐,其中+ E,uns ----- + EE表示单键或双键; R 1和R 2彼此独立地表示氢,羟基或OR基,其中R表示酰基或烷基; R3表示氢,低级烷基或卤代低级烷基,条件是当+ E时,不为 - + EE表示双键,R3不存在; R4代表氢或低级烷基; A表示式a,b,c或d的基团; R 5,R 6和R 7彼此独立地表示氢,烷基,卤代烷基,烯基或卤代烯基,或者R 6和R 7与它们所连接的氮原子一起可以形成可被R 5取代的4至8元杂环 ; X表示O,S或NR8,其中R8表示氢或低级烷基; m表示2〜15的整数, n表示0〜2的整数, p表示0〜4的整数。
-
公开(公告)号:US06645951B1
公开(公告)日:2003-11-11
申请号:US09719608
申请日:2001-07-16
申请人: Jae Chon Jo , Hyun Suk Lim , Jong Min Kim , Ju Su Kim , Kazumi Morikawa , Yoshitake Kanbe , Myung Hwa Kim , Masahiro Nishimoto
发明人: Jae Chon Jo , Hyun Suk Lim , Jong Min Kim , Ju Su Kim , Kazumi Morikawa , Yoshitake Kanbe , Myung Hwa Kim , Masahiro Nishimoto
IPC分类号: C07D33506
CPC分类号: C07D335/06 , C07D311/58 , C07D405/04 , C07D405/06 , C07D407/06 , C07D413/06 , C07D417/06
摘要: The present invention provides novel benzopyran compounds, pharmaceutically acceptable salts thereof and stereoisomers thereof where the benzopyran compounds of the invention are compounds according to Formula I: The present invention further provides pharmaceutical compositions which possess anti-estrogenic activity and comprise at least one benzopyran compound of the invention and a method of treating breast cancer by administration of an effective amount of a benzopyran compound provided by the present invention.
摘要翻译: 本发明提供新的苯并吡喃化合物,其药学上可接受的盐和立体异构体,其中本发明的苯并吡喃化合物是式I的化合物。本发明还提供了具有抗雌激素活性的药物组合物,并且包含至少一种苯并吡喃化合物 本发明和通过施用有效量的本发明提供的苯并吡喃化合物来治疗乳腺癌的方法。
-
-